| N patients witd available clinical follow-up | 111/138 (80.4) |
| Duration of follow-up (days) | 180 ± 104 |
| N patients with thrombo-embolic events | 2/111 (1.8) |
| TIA | 2/111 (1.8) |
| N patients with TOE | 103/138 (74.6) |
| Mean timespan from LAA ligation to TOE (days) | 176 ± 73 |
| N patients with complete LAA closure | 100/103 (97.1) |
| N patients with LA thrombus | 2/103 (1.9) |
| N patients witd available clinical follow-up | 111/138 (80.4) |
| Duration of follow-up (days) | 180 ± 104 |
| N patients with thrombo-embolic events | 2/111 (1.8) |
| TIA | 2/111 (1.8) |
| N patients with TOE | 103/138 (74.6) |
| Mean timespan from LAA ligation to TOE (days) | 176 ± 73 |
| N patients with complete LAA closure | 100/103 (97.1) |
| N patients with LA thrombus | 2/103 (1.9) |
LA, left atrium; LAA, left atrial appendage; TIA, transient ischemic attack; TOE, transoesophageal echocardiography.
| N patients witd available clinical follow-up | 111/138 (80.4) |
| Duration of follow-up (days) | 180 ± 104 |
| N patients with thrombo-embolic events | 2/111 (1.8) |
| TIA | 2/111 (1.8) |
| N patients with TOE | 103/138 (74.6) |
| Mean timespan from LAA ligation to TOE (days) | 176 ± 73 |
| N patients with complete LAA closure | 100/103 (97.1) |
| N patients with LA thrombus | 2/103 (1.9) |
| N patients witd available clinical follow-up | 111/138 (80.4) |
| Duration of follow-up (days) | 180 ± 104 |
| N patients with thrombo-embolic events | 2/111 (1.8) |
| TIA | 2/111 (1.8) |
| N patients with TOE | 103/138 (74.6) |
| Mean timespan from LAA ligation to TOE (days) | 176 ± 73 |
| N patients with complete LAA closure | 100/103 (97.1) |
| N patients with LA thrombus | 2/103 (1.9) |
LA, left atrium; LAA, left atrial appendage; TIA, transient ischemic attack; TOE, transoesophageal echocardiography.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
